By G HossainPosted on December 15, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II studies. Sobi Makes $1.5B Gout Play With Arthrosi Acquisition Post navigation Tax Fraud Blotter: Reality hitsSanofi Taps Dren Again in up to $1.7B Autoimmune Partnership